DB19080InvestigationalProtein Based Therapies
Freneslerbart is under investigation in clinical trial NCT04981717 (A Study to Examine the Efficacy and Safety of Anti-fel D 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic...
- Also known as
- Anti-cat allergen fel d 1 monoclonal anitbody regn-1908 · Immunoglobulin G4 [227-proline], anti-(Felis catus allergen Fel d1) (human monoclonal REGN1908 γ4-chain), disulfide with human monoclonal REGN1908 κ-chain, dimer
- Code names
- REGN-1908
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Freneslerbart, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account